Holen Sie sich die Stockscreener-App
6.23
4.30%
0.30
Schlusskurs vom Vortag:
$5.93
Offen:
$6.01
24-Stunden-Volumen:
332.49K
Relative Volume:
0.91
Marktkapitalisierung:
$115.94M
Einnahmen:
$109.43M
Nettoeinkommen (Verlust:
$5.13M
KGV:
23.91
EPS:
0.2606
Netto-Cashflow:
$18.57M
1W Leistung:
-8.23%
1M Leistung:
-29.31%
6M Leistung:
-64.31%
1J Leistung:
-13.50%
1-Tages-Spanne:
$5.96
$6.27
1-Wochen-Bereich:
$5.915
$7.0471
52-Wochen-Spanne:
$5.54
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Firmenname
Optimizerx Corp
Sektor
Branche
Telefon
248-651-6558
Adresse
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
6.22 | 110.54M | 109.43M | 5.13M | 18.57M | 0.2606 |
|
VEEV
Veeva Systems Inc
|
179.38 | 29.72B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
50.70 | 8.85B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.25 | 7.42B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.92 | 6.56B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.12 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-02-02 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-11-01 | Eingeleitet | Stifel | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-01-03 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
Should you sell your OptimizeRx stock? - Cantech Letter
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $20.00 by Analysts at Lake Street Capital - MarketBeat
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $18.00 by Analysts at Roth Mkm - MarketBeat
OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty - Bitget
Assessing OptimizeRx: Insights From 4 Financial Analysts - Benzinga
B. Riley Financial Reaffirms Buy Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat
OptimizeRx (OPRX) Target Price Lowered by Stephens & Co. | OPRX Stock News - GuruFocus
Stephens Cuts OptimizeRx (NASDAQ:OPRX) Price Target to $10.00 - MarketBeat
OptimizeRx (NASDAQ:OPRX) Announces Quarterly Earnings Results - MarketBeat
Stephens cuts OptimizeRx stock price target on soft pharma budgets - Investing.com Nigeria
OptimizeRx Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript - AOL.com
Stifel cuts OptimizeRx stock price target on pharma spend slowdown - Investing.com
Stephens cuts OptimizeRx stock price target on soft pharma budgets By Investing.com - Investing.com South Africa
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
OptimizeRx Corp (OPRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
OptimizeRx Q4 Earnings Call Highlights - MarketBeat
Stock Repurchase Plan Initiated by OptimizeRx (NASDAQ:OPRX) Board of Directors - MarketBeat
From loss to profit: OptimizeRx posts record $109.4M sales and $10M buyback - Stock Titan
Earnings call transcript: OptimizeRx Q4 2025 earnings beat expectations amid cautious market - Investing.com
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
OPTIMIZERx earnings beat by $0.29, revenue topped estimates - Investing.com Canada
UPDATEOptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Optimizerx Corp enters amendment no. 4 to financing agreementSEC filing - marketscreener.com
OptimizeRx Reports Strong Q4 2025 Results with Record Net Income and Adjusted EBITDA, Updates 2026 Revenue Guidance and Announces Share Repurchase Program - Quiver Quantitative
Optimizerx Corp Enters Amendment No. 4 To Financing Agreement- SEC Filing - TradingView
OptimizeRx Q4 Adjusted Earnings Rise; Reports Buyback Program - marketscreener.com
Geopolitics Watch: Can OptimizeRx Corporation sustain earnings growthTrade Performance Summary & Smart Money Movement Tracker - baoquankhu1.vn
OptimizeRx Authorizes $10 Million Share Repurchase Program - TipRanks
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
OptimizeRx (Nasdaq: OPRX) returns to profit and unveils $10M share repurchase plan - Stock Titan
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 P.m. ET - 富途牛牛
Earnings To Watch: OptimizeRx Corp (OPRX) Reports Q4 2025 Result - GuruFocus
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
OptimizeRx Corp expected to post earnings of 23 cents a shareEarnings Preview - TradingView
OPRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Portfolio Update: Can OptimizeRx Corporation weather a recessionMarket Volume Summary & Pattern Based Trade Signal System - baoquankhu1.vn
OptimizeRx (OPRX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Can OptimizeRx Corporation sustain earnings growthQuarterly Trade Review & Breakout Confirmation Alerts - mfd.ru
Is OptimizeRx Corporation stock trending bullishPortfolio Return Summary & Step-by-Step Trade Execution Guides - mfd.ru
CenterBook Partners LP Invests $6.33 Million in OptimizeRx Corp. $OPRX - MarketBeat
OptimizeRx (OPRX): Small-Cap AI Health Stock Quietly Repricing Higher - AD HOC NEWS
US Market Recap: Can OptimizeRx Corporation maintain sales growthEarnings Beat & Long-Term Growth Plans - baoquankhu1.vn
Autoship and Rx: The Backbone for Hitting Chewy's Margin Target - AOL.com
Brokerages Set OptimizeRx Corp. (NASDAQ:OPRX) Price Target at $21.00 - Defense World
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Portfolio Update: Can OptimizeRx Corporation sustain earnings growth2025 Price Targets & Daily Volume Surge Trade Alerts - baoquankhu1.vn
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET - The Manila Times
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial - GlobeNewswire
Finanzdaten der Optimizerx Corp-Aktie (OPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):